RecruitingPhase 4NCT07202117

PLLA and CaHA-R for Aesthetic Rejuvenation

Studying Autoimmune hemolytic anemia, cold type

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Erevna Innovations Inc.
Principal Investigator: Andreas Nikolis, MD, PhD
Erevna Innovations Inc.
Intervention: Sculptra Aesthetic(device)
Enrollment: 45 enrolled
Eligibility: 21 years · FEMALE
Timeline: 2025 – 2026

Study locations (1)

Erevna Innovations Inc., Montreal, Quebec, Canada

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07202117 on ClinicalTrials.gov

Other trials for Autoimmune hemolytic anemia, cold type

Additional recruiting or active studies for the same condition.

RECRUITINGNCT05931718
Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

See all trials for Autoimmune hemolytic anemia, cold type →

← Back to all trials